Stratipath brings together physicians, researchers, AI-scientists, developers and industry specialists with its aim to help all patients get the right treatment through precision diagnostics. Stratipath is a spin-out from Karolinska Institutet in Stockholm, Sweden, bringing pioneering research from the fields of AI and precision medicine into clinical use. The company was founded in 2019 with a mission to radically improve cancer treatment decisions and patient outcomes. Stratipath uses AI technology and research to improve cancer diagnostics for more patients. Today far too many patients receive inconclusive cancer diagnoses and have unequal access to precision diagnostics. Stratipath’s AI technology can change this by providing patients with faster access to novel, more conclusive and precise results, at a sustainable cost.

• We want our staff to be diverse and recruitment to be non-excluding. We welcome diversity regardless of gender, gender identity or expression, race, nationality, age, sexual orientation, or other forms of diversity.
• We make decisions about recruitment, hiring, reward, development, and promotion based only on ability, experience, behaviour toward others, work performance, and demonstrated potential in relation to the job.
• We develop employee talent and support everyone in achieving their potential.